Article

Shifting The Paradigm for Retinal Disease Management

Trouble viewing this PDF?

Click to download

If you are unable to download this pdf file, please try again in another browser.


Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children
January 30th 2025

Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Harrow launches Harrow Cares program in partnership with Cencora
January 29th 2025

Harrow launches Harrow Cares program in partnership with Cencora

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

ARVO Foundation reveals 2025 Dr David L Epstein Award recipients
January 28th 2025

ARVO Foundation reveals 2025 Dr David L Epstein Award recipients

Viralgen and Axovia Therapeutics partner to manufacture gene therapy for Bardet-Biedl Syndrome
January 28th 2025

Viralgen and Axovia Therapeutics partner to manufacture gene therapy for Bardet-Biedl Syndrome

© 2025 MJH Life Sciences

All rights reserved.